Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Download PDF
May 3, 2016
/
News
Share
the Post
Related
Posts
Factsheet on updated WHO guidelines for the screening, care and treatment of persons with hepatitis C infection from TREAT Asia/amfAR
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Pricing and availability of generic Indian daclatasvir as on 7 March 2016
Up dated Generic Sofosbuvir availability and Price in India – 18 May 2015
Four Indian generic companies take sub license from MPP on daclatasvir
Updated Patent Situation on Key Products for Hepatitis C Treatment in Asia – August 2015
Updated Generic Sofosbuvir Availability and Price in India 15 June 2015
The Updated Pricing of Ledipasvir and Sofosbuvir Co-formulated tablets
